| 2008-December-23 |
Appendix 3Y - Change of Director's Interest Notice (in PDF) |
| 2008-December-23 |
Appendix 3Y - Change of Director's Interest Notice (in PDF) |
| 2008-December-23 |
Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement (in PDF) |
| 2008-November-27 |
Results of Annual General Meeting (in PDF) |
| 2008-November-27 |
The Year in Review Address by Brian Jamieson - Chairman, Mesoblast Limited Annual General Meeting 2008 (in PDF) |
| 2008-November-24 |
The CEO Transcript - Investor Briefing with Silviu Itescu, Executive Director, Mesoblast Limited (in PDF) |
| 2008-November-14 |
Frost & Sullivan Select Proprietary Technology Platform as U.S. Stem Cell Market Innovation of the Year (in PDF) |
| 2008-November-11 |
Proprietary Stem Cells for Heart Failure Highlighted at Major Cardiology Conference in United States (in PDF) |
| 2008-November-7 |
Mesoblast Featured at UBS Healthcare - Investor Conference (in PDF) |
| 2008-November-5 |
Bone Marrow Transplant Trial Using Proprietary Cell Therapy Receives United States FDA Clearance and Institutional Ethics Approval (in PDF) |
| 2008-October-31 |
Appendix 4C - Quarterly Report for Entities Admitted on the Basis of Commitments (in PDF) |
| 2008-October-24 |
Notice of 2008 Annual General Meeting (in PDF) |
| 2008-October-13 |
First Heart Failure Patients Successfully Implanted in United States (in PDF) |
| 2008-October-8 |
Appendix 3Y - Change of Director's Interest Notice (in PDF) |
| 2008-September-30 |
Appendix 3Y - Change of Director's Interest Notice (in PDF) |
| 2008-September-30 |
Appendix 3Y - Change of Director's Interest Notice (in PDF) |
| 2008-September-30 |
Appendix 3Y - Change of Director's Interest Notice (in PDF) |
| 2008-September-30 |
Appendix 3Y - Change of Director's Interest Notice (in PDF) |
| 2008-September-25 |
UBS Life Sciences Investor Conference Features Angioblast (in PDF) |
| 2008-September-23 |
Mesoblast Commercial Leadership Featured at World Stem Cell Summit (in PDF) |
| 2008-September-17 |
FDA Grants Orphan Drug Designation for Use of Proprietary Stem Cells in Bone Marrow Transplants (in PDF) |
| 2008-September-4 |
Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement (in PDF) |
| 2008-September-3 |
Appendix 3Y - Change of Director's Interest Notice (in PDF) |
| 2008-September-3 |
Appendix 3Y - Change of Director's Interest Notice (in PDF) |
| 2008-August-28 |
Appendix 4E - Preliminary Final Report Year Ending on 30 June 2008 (in PDF) |
| 2008-August-28 |
Mesoblast Reports Significant Achievements and Strong Financial Position (in PDF) |
| 2008-August-21 |
Mesoblast's Allogeneic, "Off-The-Shelf", Stem Cells Are Safe and Effective for Cervical Spine Fusion (in PDF) |
| 2008-August-12 |
Mesoblast's Stem Cells Regrow Knee Cartilage In Severe Post-Menopausal Osteoarthritis Company To Commercialise Product For Broader Knee Cartilage Markets (in PDF) |
| 2008-August-7 |
Mesoblast - National Electronic Media Coverage (in PDF) |
| 2008-August-6 |
Non-Healing Bones Repaired in Clinical Trial Using Adult Stem Cells (in PDF) |
| 2008-July-31 |
Appendix 4C - Quarterly Report for Entities Admitted on the Basis of Commitments (in PDF) |
| 2008-July-21 |
The CEO Transcript - Investor Briefing with Silviu Itescu, Founder and Executive Director, Mesoblast Limited (in PDF) |
| 2008-July-16 |
Key Stem Cell Patent Granted in United States (in PDF) |
| 2008-July-10 |
Allogeneic Stem Cells Effectively Treat Eye Diseases (in PDF) |
| 2008-June-5 |
United States FDA Clears Phase 2 Trial for Congestive Heart Failure (in PDF) |
| 2008-May-13 |
Near-Term Commercialisation of Three Bone and Cartilage Products (in PDF) |
| 2008-April-29 |
Appendix 4C - Quarterly Report for Entities Admitted on the Basis of Commitments (in PDF) |
| 2008-April-17 |
Mesoblast's Cells Show Long-lasting and Sustained Effect in Knee Osteoarthritis, Company to Commence Phase 2 Clinical Trail for Knee Cartilage Protection (in PDF) |
| 2008-April-9 |
Spinal Fusion Clinical Program Update, Accelerated Timetable to Registration Trial (in PDF) |
| 2008-April-7 |
U.S. Heart Attack Trial Update, 'Most Exciting Stem Cell Therapy In Heart Research Today' (in PDF) |
| 2008-February-27 |
Appendix 4D - Half Year Report for the Six Months to 31 December 2007 (in PDF) |
| 2008-February-27 |
Mesoblast Half Year Results; Company Well Resourced to Execute Clinical and Commercial Strategic Objectives (in PDF) |
| 2008-February-19 |
Agreement with Abbott for Catheter-Based Stem Cell Heart Failure Therapy (in PDF) |
| 2008-February-13 |
Highly Successful Results of Bone Repair Trial Show that Mesoblast's Stem Cells Promote and Repair Fracture Healing (in PDF) |
| 2008-January-31 |
Appendix 4C - Quarterly Report for Entities Admitted on the Basis of Commitments (in PDF) |
| 2017 |
2017 Announcements / Press Releases |
| 2016 |
2016 Announcements / Press Releases |
| 2015 |
2015 Announcements / Press Releases |
| 2014 |
2014 Announcements / Press Releases |
| 2013 |
2013 Announcements / Press Releases |
| 2012 |
2012 Announcements / Press Releases |
| 2011 |
2011 Announcements / Press Releases |
| 2010 |
2010 Announcements / Press Releases |
| 2009 |
2009 Announcements / Press Releases |
| 2007 |
2007 Announcements / Press Releases |
